Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.

Gleeson D, Chapman S, McAteer H, Qin A, Gregory J, Pizzato J, Powell K, Sagoo MK, Ye W, Naylor A, Moorhead L, Pink AE, Woolf R, Barker J, Galloway JB, Cro S, K Mahil S, Smith CH

Open source

DOI
10.1136/bmjopen-2025-106361
Published
2025 Aug 21
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2025-106361,
  title = {Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.},
  author = {Gleeson D and Chapman S and McAteer H and Qin A and Gregory J and Pizzato J and Powell K and Sagoo MK and Ye W and Naylor A and Moorhead L and Pink AE and Woolf R and Barker J and Galloway JB and Cro S and K Mahil S and Smith CH},
  year = {2025},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2025-106361},
  url = {https://doi.org/10.1136/bmjopen-2025-106361}
}

RIS

TY  - JOUR
TI  - Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.
AU  - Gleeson D
AU  - Chapman S
AU  - McAteer H
AU  - Qin A
AU  - Gregory J
AU  - Pizzato J
AU  - Powell K
AU  - Sagoo MK
AU  - Ye W
AU  - Naylor A
AU  - Moorhead L
AU  - Pink AE
AU  - Woolf R
AU  - Barker J
AU  - Galloway JB
AU  - Cro S
AU  - K Mahil S
AU  - Smith CH
PY  - 2025
JO  - BMJ open
DO  - 10.1136/bmjopen-2025-106361
UR  - https://doi.org/10.1136/bmjopen-2025-106361
ER  - 

APA

D, G., S, C., H, M., A, Q., J, G., J, P., K, P., MK, S., W, Y., A, N., L, M., AE, P., R, W., J, B., JB, G., S, C., S, K. M., & CH, S. (2025). Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.. BMJ open. https://doi.org/10.1136/bmjopen-2025-106361

Source records